| Application no. and date | 01904167.2 (espacenet) (Federated) (European Patent Register), 20010212 | | Patent/reg. no. and date | DK/EP 1263739, 20080102 | | Publication date | 20021211 | | Priority no. and date | GB 0003305, 20000215 | | EP pub. no. and date |
EP 1263739 20021211 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE,
SHIONOGI & CO., LTD., 1-8, Doshomachi 3-chome,
Chuo-ku
Osaka 541-0045, JP | | Applicant ref. no. | AST Z70666-1X | | Inventor | Taylor, Nigel, Philip, Alderley Park
Macclesfield
Cheshire SK10 4TG, GB,
Okada, Tetsuo, 12-4, Sagisu 5-chome
Fukushima-ku
Osaka-shi
Osaka 553-0002, JP | | Representative | | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61P 3/06 (2006.01) , C07D 239/42 (2006.01) | | Title | Krystallinske salte af 7-[4-(4-fluorphenyl)-6-isopropyl-2-methyl(methylsulfonyl) aminopyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoinsyre | | Int. application no. | GB2001000574 | | Int. publication no. | WO2001060804 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
